Skip to main content

Peer Review reports

From: Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation

Original Submission
2 Apr 2024 Submitted Original manuscript
27 Jun 2024 Reviewed Reviewer Report
14 Jul 2024 Reviewed Reviewer Report
26 Jul 2024 Author responded Author comments - Naohisa Urabe
Resubmission - Version 2
26 Jul 2024 Submitted Manuscript version 2
8 Aug 2024 Author responded Author comments - Naohisa Urabe
Resubmission - Version 3
8 Aug 2024 Submitted Manuscript version 3
17 Aug 2024 Reviewed Reviewer Report
28 Aug 2024 Reviewed Reviewer Report
29 Aug 2024 Author responded Author comments - Naohisa Urabe
Resubmission - Version 4
29 Aug 2024 Submitted Manuscript version 4
Publishing
2 Sep 2024 Editorially accepted
10 Sep 2024 Article published 10.1186/s12890-024-03261-w

You can find further information about peer review here.

Back to article page